QQ客服 官方微博 反馈留言

	Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome [Reducci n del inhibidor de la fibrin lisis activado por trombina y aumento de las citocinas proinflamatorias en pacientes son s ndro
	Pang H.; Zhang C.; Liu F.; Gong X.; Jin X.; Su C.
刊名	Medicina Intensiva
	2017
卷号	41页码:475-482
ISSN号	02105691
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3306160
专题	大连理工大学
作者单位	1.Department of Biomedical Engineering, Dalian University of Technology, No. 2 Ling Gong Road, Ganjingzi District, Dalian city, China 2.Vasculocardiology Department of the First Affiliated Hospital, Jinzhou Medical University, No. 2 of Street 5, Guta District, Jinzhou city, China 3.Technology Center of Liaoning MEDI Biological Company, No. 166 of Xianghuai Road, Economic and Technological Development Zone, Benxi city, China
推荐引用方式 GB/T 7714	Pang H.,Zhang C.,Liu F.,et al. Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome [Reducci n del inhibidor de la fibrin lisis activado por trombina y aumento de las citocinas proinflamatorias en pacientes son s ndro[J]. Medicina Intensiva,2017,41:475-482.
APA	Pang H.,Zhang C.,Liu F.,Gong X.,Jin X.,&Su C..(2017).Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome [Reducci n del inhibidor de la fibrin lisis activado por trombina y aumento de las citocinas proinflamatorias en pacientes son s ndro.Medicina Intensiva,41,475-482.
MLA	Pang H.,et al."Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome [Reducci n del inhibidor de la fibrin lisis activado por trombina y aumento de las citocinas proinflamatorias en pacientes son s ndro".Medicina Intensiva 41(2017):475-482.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。